Completed PHASE1 INTERVENTIONAL 1-arm NCT00002537

Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer

A PHASE I STUDY OF PROLONGED LOW-DOSE TOPOTECAN INFUSION COMBINED WITH CHEST IRRADIATION

Sponsor: National Cancer Institute (NCI)

Interventions radiation therapy topotecan hydrochloride

Updated 6 times since 2017 Last updated: Feb 8, 2013 Started: Sep 30, 1993 Primary completion: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00002537, this PHASE1 trial focuses on Lung Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 6 times since 1993, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States